#Global Aneurysm Coiling Market

[lalsingh228-blog]

Aneurysm Coiling Market May Set New Growth Story

Advance Market Analytics added research publication document on Worldwide Aneurysm Coiling Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Aneurysm Coiling market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till 2028*. Some are the key & emerging players that are part of coverage and have being profiled are Johnson and Johnson Services, Inc. (United States), MicroVention, Inc. (United States), Stryker Corporation (United States), Boston Scientific Corporation (United States), Medtronic plc (Ireland), Cardinal Health (United States), MicroPort (China), Cook Medical Incorporated (United States), B. Braun (Germany), Integra LifeSciences (United States). Get free access to Sample Report in PDF Version along with Graphs and Figures @ https://www.advancemarketanalytics.com/sample-report/169381-global-aneurysm-coiling-market

An aneurysm coil is a device inserted via a catheter to fill in a brain aneurysm a bulge in a blood vessel. Aneurysm coiling induces clotting (embolization) of the aneurysm and, in this way, prevents blood from getting into it. Aneurysm coiling prevents rupture that closes off the blood flow into the aneurysm by packing it tightly with detachable platinum coils. The factors such as Increased Prevalence of Cerebrovascular Disorders, Increased Adoption of Minimally Invasive Surgeries and Development of New Diagnostic Centres and Hospitals in Developing Countries are the key drivers for the global Aneurysm Coiling market. In addition, Rise in the Number of Surgeries Performed Worldwide also fueling the market growth. However, Complications Associated with Aneurysm Coiling may hamper the market growth.

Keep yourself up-to-date with latest market trends and changing dynamics due to COVID Impact and Economic Slowdown globally. Maintain a competitive edge by sizing up with available business opportunity in Aneurysm Coiling Market various segments and emerging territory. Influencing Market Trend

Rise in the Number of Surgeries Performed Worldwide

Market Drivers

Increased Prevalence of Cerebrovascular Disorders

Increased Adoption of Minimally Invasive Surgeries

Development of New Diagnostic Centres and Hospitals in Developing Countries

Opportunities:

Increasing Number of Target Patient Population

Growth in the Healthcare Industry Worldwide

Increasing Incidence of Intracranial Aneurysms

Challenges:

Lack of Skilled Surgeons

Have Any Questions Regarding Global Aneurysm Coiling Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/169381-global-aneurysm-coiling-market Analysis by Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), Application (Hospitals, Ambulatory Surgical Centres)

Competitive landscape highlighting important parameters that players are gaining along with the Market Development/evolution

• % Market Share, Segment Revenue, Swot Analysis for each profiled company [Johnson and Johnson Services, Inc. (United States), MicroVention, Inc. (United States), Stryker Corporation (United States), Boston Scientific Corporation (United States), Medtronic plc (Ireland), Cardinal Health (United States), MicroPort (China), Cook Medical Incorporated (United States), B. Braun (Germany), Integra LifeSciences (United States)]

• Business overview and Product/Service classification

• Product/Service Matrix [Players by Product/Service comparative analysis]

• Recent Developments (Technology advancement, Product Launch or Expansion plan, Manufacturing and R&D etc)

• Consumption, Capacity & Production by Players The regional analysis of Global Aneurysm Coiling Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Whereas, owing to rising no. of research activities in countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate the forecast period 2023-2028. Table of Content Chapter One: Industry Overview Chapter Two: Major Segmentation (Classification, Application and etc.) Analysis Chapter Three: Production Market Analysis Chapter Four: Sales Market Analysis Chapter Five: Consumption Market Analysis Chapter Six: Production, Sales and Consumption Market Comparison Analysis Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis Chapter Eight: Competition Analysis by Players Chapter Nine: Marketing Channel Analysis Chapter Ten: New Project Investment Feasibility Analysis Chapter Eleven: Manufacturing Cost Analysis Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers Read Executive Summary and Detailed Index of full Research Study @ https://www.advancemarketanalytics.com/reports/169381-global-aneurysm-coiling-market Highlights of the Report • The future prospects of the global Aneurysm Coiling market during the forecast period 2023-2028 are given in the report. • The major developmental strategies integrated by the leading players to sustain a competitive market position in the market are included in the report. • The emerging technologies that are driving the growth of the market are highlighted in the report. • The market value of the segments that are leading the market and the sub-segments are mentioned in the report. • The report studies the leading manufacturers and other players entering the global Aneurysm Coiling market. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[deshpandeisha]

Overview of Neurovascular Devices: Innovations and Applications

The global neurovascular devices market size was USD 2.84 Billion in 2022 and is expected to register a steady revenue CAGR of 6.0% during the forecast period, according to latest analysis by Emergen Research. The neurovascular devices market is witnessing significant growth and innovation as it plays a crucial role in the diagnosis and treatment of various neurological conditions affecting the blood vessels of the brain and spinal cord. Neurovascular devices are used in procedures such as embolization, angioplasty, and stenting to address conditions like aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. The global neurovascular devices market is being driven by factors such as the increasing prevalence of neurological disorders, advancements in technology, growing aging population, and rising demand for minimally invasive procedures.

One of the primary drivers behind the growth of the neurovascular devices market is the rising prevalence of neurological disorders worldwide. According to the World Health Organization (WHO), neurological disorders affect millions of people globally, with conditions such as strokes, aneurysms, and AVMs contributing significantly to the disease burden. The increasing awareness about these conditions, along with improved access to healthcare services, has led to higher diagnosis rates and subsequent demand for neurovascular devices. Additionally, technological advancements in imaging techniques and treatment modalities have facilitated early detection and precise interventions, further driving market growth.

Technological advancements and innovations in neurovascular devices have revolutionized the field, contributing to market growth. For instance, the development of advanced imaging techniques, such as digital subtraction angiography (DSA), magnetic resonance imaging (MRI), and computed tomography (CT), has enhanced the diagnosis and treatment planning for neurovascular conditions. Additionally, the introduction of minimally invasive procedures, including endovascular coiling and stenting, has significantly reduced the risks associated with traditional open surgeries and improved patient outcomes. The continuous evolution of neurovascular devices, including the use of bioresorbable materials and drug-eluting stents, further augments the market growth potential.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1932

Competitive Terrain:

The global Neurovascular Devices industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Stryker, Medtronic, Johnson and Johnson Services Inc., Microvention Inc., W. L. Gore & Associates, Inc., Merit Medical Systems., Penumbra, Inc., Lumenis Be Ltd., Acandis GmbH, and Codman Neurosurgery

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Neurovascular Devices market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Neurovascular Devices market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Neurovascular Devices market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1932

Market Segmentations of the Neurovascular Devices Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Neurovascular Devices market on the basis of product, application, and region:

Segments Covered in this report are:

Device Type Outlook (Revenue, USD Billion; 2019-2032)

Cerebral Embolization and Aneurysm Coiling Devices

Neurothrombectomy Devices

Cerebral Angioplasty and Stenting Systems

Support Devices

Application Outlook (Revenue, USD Billion; 2019-2032)

Cerebral Artery Stenosis

Stroke

Ischemic Stroke

Arteriovenous Malformations

Others

End-use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals

Specialty Clinics

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/neurovascular-devices-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1932

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[health-views-updates]

Neurovascular Devices Market Predictions: Expert Insights on What's Next

The global neurovascular devices market revenue is set for steady growth, with a projected compound annual growth rate (CAGR) of 6.05% from 2024 to 2031. Valued at USD 3.01 billion in 2023, the market is expected to reach USD 4.81 billion by 2030. This growth highlights the increasing demand for innovative treatments and devices aimed at managing neurovascular diseases, such as strokes, aneurysms, and arteriovenous malformations.

Neurovascular devices are used to treat a variety of conditions affecting the blood vessels in the brain and central nervous system. These devices include stents, embolization coils, catheters, flow diverters, and clot retrieval devices. The market growth is driven by advancements in minimally invasive procedures, the increasing prevalence of neurovascular diseases, and the aging global population.

Key Market Drivers

Rising Prevalence of Neurovascular Diseases: Stroke, cerebral aneurysms, and other neurovascular disorders are becoming increasingly common worldwide. Stroke is a leading cause of death and long-term disability, creating a growing need for effective treatments. As the global population ages, the incidence of neurovascular conditions is expected to rise, driving demand for advanced treatment options.

Technological Advancements in Neurovascular Devices: Advances in neurovascular devices, particularly in minimally invasive procedures, are significantly contributing to market growth. Innovations such as next-generation stent retrievers, embolization coils, and flow diverters are providing better outcomes for patients by reducing recovery times and minimizing complications. These advancements have also improved the effectiveness of procedures for both ischemic and hemorrhagic strokes, further driving adoption.

Growing Awareness and Adoption of Minimally Invasive Surgeries: Minimally invasive surgeries are gaining traction as they offer several advantages over traditional open surgeries, including reduced hospital stays, quicker recovery times, and fewer complications. This trend is particularly relevant in the treatment of neurovascular diseases, where minimally invasive procedures, such as mechanical thrombectomy for stroke, are becoming the standard of care. The growing preference for these procedures is driving the demand for neurovascular devices.

Increasing Healthcare Expenditure and Infrastructure: Governments and healthcare organizations are investing heavily in the development of healthcare infrastructure, particularly in emerging markets. This has led to increased access to advanced medical technologies, including neurovascular devices. Coupled with rising healthcare expenditure, this trend is expected to fuel market growth over the forecast period.

Get Free Sample Report: https://www.snsinsider.com/sample-request/1781

Challenges and Opportunities

While the neurovascular devices market is set for growth, several challenges remain. High device costs, along with the complex nature of neurovascular procedures, can limit access, particularly in developing regions. Additionally, the stringent regulatory landscape for medical devices can create barriers to market entry for smaller companies and delay the introduction of new products.

However, these challenges present opportunities for innovation. Companies are investing in the development of cost-effective, user-friendly devices that can expand access to advanced neurovascular treatments. Moreover, increasing research into neurovascular diseases and their treatment options is expected to lead to the development of new, more effective devices.

Regional Insights

North America currently holds the largest share of the neurovascular devices market, driven by the high prevalence of neurovascular disorders, advanced healthcare infrastructure, and robust research and development activities. Europe follows closely, with significant investments in healthcare and medical device technologies.

The Asia-Pacific region is expected to witness the highest growth over the forecast period. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of neurovascular diseases in countries such as China, Japan, and India are key factors driving growth in this region. Additionally, government initiatives to promote medical device manufacturing and innovation in the region are expected to support market expansion.

Future Outlook

The neurovascular devices market is poised for sustained growth over the next decade. With a projected CAGR of 6.05% from 2024 to 2031, the market is expected to reach USD 4.81 billion by 2030. Factors such as technological advancements, the growing prevalence of neurovascular diseases, and increasing adoption of minimally invasive procedures will continue to drive demand for neurovascular devices.

As healthcare providers and governments increasingly focus on improving outcomes for patients with neurovascular conditions, the market is likely to see further innovation and growth. The ongoing development of advanced devices and expanding access to neurovascular treatments in emerging markets will be critical to shaping the future of the industry.

Other Trending Reports

Heart Failure POC & LOC Devices Market

Protein Engineering Market

Alzheimer's Therapeutics Market

Protein Labeling Market

[industryforecastnews]

Neurovascular Devices Market Size To Reach USD 4.53 Billion By 2030

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Neurovascular Devices Market Report Highlights

In 2022, cerebral embolization and aneurysm coiling devices dominated the neurovascular devices market with a market share of 34.79%. As the prevalence of cerebral artery stenosis rises, major players are introducing more technologically advanced products

Based on therapeutic application, stroke segment dominated the market in 2022 with a market share of 57.10% due to the increasing prevalence of stroke, globally. The increasing frequency of strokes around the world has resulted in a significant demand for the management of these cases, necessitating the intensive use of neurovascular devices

Among size, 0.021" held a majority market share of 27.26% in the year 2022. This is due to 0.021” size products are preferred over others owing to superior flow rates and embolic compatibility

Among end use, hospitals held a majority market share of 70.97% in the year 2022. Increasing number of patients being admitted to the hospitals due to the surgeries, therapies, and treatments is expected to favor the neurovascular device market. Thus, subsequent increase in number of patients across the globe, launch of technologically advanced products, and favorable reimbursement policies are leading to a growing demand for the hospital treatments

North America led the market with the maximum revenue share of 26.44% in 2022. Rising demand for the minimally invasive surgeries, and increasing government initiative for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment

Regional Insights

North America dominated the neurovascular devices market with the share of 26.44% in 2022 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region. In February 2023, Phenox Inc. stated that their pRESET Thrombectomy Device has been cleared by the FDA for use in the treatment of acute ischemic stroke. The product pRESET, which has been marketed in Europe for more than  a decade, has now been approved for use in the U.S. Furthermore, rising prevalence of neurological disorders, and increasing demand for the minimally invasive surgical procedures are driving the neurovascular devices market growth in this region.

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market based on the device, therapeutic application, size, end use, and regions:

Neurovascular Devices Device Outlook (Revenue USD Million; Volume Unit; 2018 - 2030)

Cerebral Embolization and Aneurysm Coiling Devices

Cerebral Angioplasty and Stenting Systems

Neurothrombectomy Devices

Support Devices

Trans Radial Access Devices

Neurovascular Devices Therapeutic Application Outlook (Revenue USD Million; 2018 - 2030)

Stroke

Cerebral Artery

Cerebral Aneurysm

Others

Neurovascular Devices Size (in Inches) Outlook (Revenue USD Million; 2018 - 2030)

0.027"

0.021"

0.071"

0.017"

0.019"

0.013"

0.058"

0.068"

Others

Neurovascular Devices End Use Outlook (Revenue USD Million; 2018 - 2030)

Hospitals

Specialty Clinics

Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

List of Key Players In Neurovascular Devices Market

Medtronic

Johnson and Johnson Services Inc.

Penumbra, Inc.

Micro port Scientific Corporation

Stryker

Microvention Inc. (Terumo Corporation)

Codman Neuro (Integra Life sciences)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

[trendtrackershq]

How Are Recent Innovations Shaping the Future of the Neurovascular Device Market?

Introduction:

The Neurovascular Device Market is undergoing a significant transformation driven by a series of recent innovations and breakthroughs. As the field of neurovascular intervention continues to evolve, these developments are poised to enhance patient outcomes and redefine treatment standards. This article explores how the latest advancements are shaping the future of the neurovascular device market, providing insights into the cutting-edge technologies and trends influencing the industry.

Download FREE Sample: https://www.nextmsc.com/neurovascular-device-market/request-sample

1. What Are the Latest Innovations in Neurovascular Devices?

Recent innovations in neurovascular devices are pushing the boundaries of what is possible in the treatment of cerebrovascular conditions. Key advancements include:

1.1. Advanced Stent Technologies

The development of next-generation neurovascular stents represents a significant leap forward. Companies like Medtronic and Stryker have introduced stents with improved delivery systems and enhanced biocompatibility. For instance, the Medtronic Solitaire X stent retriever has been designed to offer superior clot removal capabilities with a more precise deployment mechanism, leading to better clinical outcomes in thrombectomy procedures.

1.2. Bioresorbable Devices

Bioresorbable devices are gaining traction as a promising innovation. Unlike traditional metal stents, bioresorbable stents gradually dissolve over time, leaving behind a restored blood vessel without a permanent implant. Abbott’s Absorb BVS, though discontinued, has set a precedent for future developments in this area, highlighting the potential for bioresorbable materials to improve long-term patient outcomes.

1.3. Next-Generation Coiling Systems

Advancements in endovascular coiling systems are improving the treatment of cerebral aneurysms. Newer coiling systems, such as those developed by Penumbra, offer enhanced stability and control during deployment, which helps in better aneurysm occlusion and reduces the risk of recanalization.

2. How Are Regulatory Approvals Impacting the Market?

Regulatory approvals are crucial in determining the success of new neurovascular devices. Recent approvals and clearances have had a significant impact on the market, facilitating the introduction of innovative products.

2.1. FDA Approvals

The U.S. Food and Drug Administration (FDA) has recently approved several new neurovascular devices, including:

Cerenovus’ PulseRider: A novel device designed to treat complex intracranial aneurysms by providing a scaffold for coiling. Its approval marks a significant advancement in the management of challenging aneurysm cases.

Inari Medical’s ClotTriever: This device, designed for mechanical thrombectomy, has received FDA clearance for its effectiveness in removing large clots from deep veins, demonstrating its potential for broader applications beyond stroke treatment.

2.2. European CE Markings

In Europe, the CE Marking has been granted to several new neurovascular devices, including the Stryker Surpass Streamline stent. This approval allows for the commercialization of these devices across European markets and contributes to the global expansion of neurovascular treatment options.

3. What Role Do Emerging Markets Play in the Neurovascular Device Industry?

Emerging markets are becoming increasingly important in the neurovascular device industry. The growing healthcare infrastructure and rising prevalence of neurovascular disorders in these regions are driving market expansion.

3.1. Market Growth in Asia-Pacific

Countries in the Asia-Pacific region, such as China and India, are experiencing rapid growth in healthcare spending and infrastructure development. This growth is facilitating the adoption of advanced neurovascular devices. For example, the introduction of minimally invasive neurovascular technologies in these markets is improving treatment accessibility and driving market demand.

3.2. Expansion in Latin America and the Middle East

Similarly, Latin America and the Middle East are witnessing increased investment in healthcare infrastructure and a growing focus on advanced medical technologies. The rise in neurovascular conditions in these regions is prompting healthcare providers to seek innovative solutions, boosting the market for neurovascular devices.

4. How Is the Focus on Minimally Invasive Procedures Affecting Device Development?

The shift towards minimally invasive procedures is a major trend influencing the neurovascular device market. This focus is driving the development of new devices and techniques aimed at reducing patient recovery times and improving procedural outcomes.

4.1. Enhanced Catheter Technologies

Recent advancements in catheter technologies are enabling more precise and controlled interventions. Innovations such as the Penumbra 3D Revascularization Device are designed to enhance clot retrieval and reduce procedure-related complications.

4.2. New Imaging Techniques

The integration of advanced imaging techniques, such as 3D rotational angiography and intravascular ultrasound, is improving the accuracy of neurovascular interventions. These techniques provide detailed visualization of blood vessels, allowing for better planning and execution of procedures.

5. What Impact Do Strategic Collaborations Have on the Market?

Strategic collaborations between medical device companies, research institutions, and healthcare providers are playing a crucial role in advancing neurovascular device technology.

5.1. Industry Partnerships

Partnerships between companies like Medtronic and Boston Scientific are driving innovation through joint R&D efforts. These collaborations enable the sharing of expertise and resources, leading to the development of cutting-edge neurovascular devices and technologies.

5.2. Academic and Research Collaborations

Collaborations with academic institutions and research organizations are also contributing to the advancement of neurovascular devices. For instance, partnerships with institutions such as the Cleveland Clinic are facilitating clinical trials and research studies that support the development and validation of new devices.

6. How Are Patient-Centered Approaches Influencing Device Design?

Patient-centered approaches are increasingly influencing the design and development of neurovascular devices. The focus is shifting towards creating devices that not only improve clinical outcomes but also enhance the overall patient experience.

6.1. User-Friendly Designs

Design improvements aimed at enhancing ease of use and patient comfort are becoming more common. For example, new devices are being designed with features that simplify deployment and reduce procedural complexity, benefiting both patients and healthcare providers.

6.2. Personalized Treatment Options

Advancements in personalized medicine are influencing the development of customized neurovascular devices. Personalized treatment approaches are being integrated into device design to cater to the specific needs of individual patients, improving treatment efficacy and safety.

Conclusion

The neurovascular device market is rapidly evolving, driven by recent innovations, regulatory approvals, and emerging market opportunities. Advances in device technology, a focus on minimally invasive procedures, and strategic collaborations are shaping the future of neurovascular interventions. As the industry continues to grow and innovate, these developments are expected to enhance patient outcomes and redefine treatment standards in neurovascular care.

For stakeholders in the neurovascular device industry, staying abreast of these trends and innovations is crucial for navigating the competitive landscape and capitalizing on emerging opportunities.

[market-spy]

Neurovascular Devices Market to Surpass USD 6.04 Billion by 2031, Witnessing 8.5% CAGR Growth | SkyQuest Technology

SkyQuest projects that the Neurovascular Device Market will attain a value of USD 6.04 Billion by 2031, with a CAGR of 8.5% during the forecast period (2024-2031).  The neurovascular devices market is boosted by the growing prevalence of neurological diseases, technological advancement, and rising demand for minimally invasive processes. In recent times, many people are suffering from neurological diseases like brain aneurysm, strokes, and epilepsy, and this is resulting in a significant rise in demand for neurovascular devices. Another disease contributing to the growth of the market is acute ischemic stroke. The popularity of minimally invasive surgeries is also increasing because of the decreases risk and trauma related to these processes. Postoperative pain can be reduced with smaller incisions leading to speedy recovery. These factors are increasing the adoption of these procedures and prompting the advancement of R&D in the field. In recent times, many companies have started investing in R&D to introduce advanced minimally invasive surgical devices. The endovascular coiling utilized for treating intracranial aneurysm is one of such procedures that is widely used by physicians. These types of procedures to treat diseases are increasing the market growth of neurovascular device market.

Download a detailed overview: https://www.skyquestt.com/sample-request/neurovascular-devices-market

Increasing Adoption of Minimally Invasive Surgeries to Reduce Risks will Boost Growth Rate

in the last few years, an inclination towards minimally invasive surgeries have increased among physicians and also patients, increasing its popularity. The primary reason for this is it has very littles risk associated with it and does not create trauma among patients. Small incisions are required to perform the surgeries, which accelerates the recovery timings. These factors have immensely encouraged doctors to implement these surgery techniques. Companies and government institutions are also investing more to improve research and development in this field to increase advancement. The development of technologies like embolic coils, advanced aspiration catheters, revascularization devices for ischemic strokes are the result of R&D. Such innovative devices have encouraged this shift towards advanced neurovascular devices.

Growing Prevalence of Neurovascular Disorder with Changing Lifestyle to Influence Market Growth

The market for neurovascular devices is primarily driven by the increasing cases of neurovascular diseases like strokes or aneurysms. As per NHS England, almost 1 in 12,500 people in England have ruptured brain aneurysm each year. Moreover, brain aneurysm impacts almost 3.0% of the persons of the U.K. Therefore, this rapidly growing patient population for target diseases in the market is mainly responsible for the high consumption of neurovascular devices, resulting in market growth. Another factor positively influencing the neurovascular devices market is the aging of the global population who are extremely vulnerable to chronic diseases and require surgeries. In the past few years, people have witnessed massive lifestyle changes as it has become more fast-paced and unhealthy eating habits have increased. Such lifestyles bring in a lot of risks like diabetes, obesity, and hypertension that can lead to many targeted diseases, increasing neurovascular issues. These factors support the growth of the market.

Increasing Awareness about Neurological Disorders Promotes Neurovascular Devices North America Boosting Market Growth

North America accounts for the dominant market share of neurovascular devices. This can be attributed to factors like increased awareness of neurological disorders, growing geriatric population, and advanced medical care infrastructure. There are also many key players present in the region creating developmental strategies to boost market growth. The market of the Asia-Pacific region is also growing rapidly due to huge population and increasing expenditure on advanced healthcare systems. Rise in disposable is also positively influencing the market as it is encouraging the adoption of neurovascular devices.

Neurovascular Devices Market Insights

Drivers:

Strategic partnerships among key market players to increase the demand for the neurovascular device with advanced products.

Rising geriatric population to create lucrative opportunities for the market.

Emphasis on patient outcome and quality of life is a major factor contributing to the growth.

Better reimbursement policies are accelerating the demand for neurovascular devices.

Restraints:

Strict regulations are an important factor that is decreasing the viability of the market

High expense of neurovascular processes is restraining the market growth

Very less access to advanced healthcare facilities, especially in developing regions can be a challenge

High risk of complications and adverse events can impede the development of the market

Key Players in Neurovascular Market

Acandis GmbH

Asahi Intecc Co. Ltd.

Imperative Care Inc.

Integer Holdings Corporation

Johnson & Johnson

Medtronic plc

MicroPort Scientific Corporation

Penumbra Inc.

Perflow Medical Ltd.

Rapid Medical

Stryker Corporation

Key Questions Answered in the Neurovascular Market

Which are the key players of the neurovascular Market?

What are the critical drivers of the market?

Which region is leading the neurovascular market?

What is neurovascular market growth?

This report provides the following insights:

Analysis of key drivers (Strategic collaboration among companies, rising geriatric population, Emphasis on patient outcome and quality of life, and Better reimbursement), restraints (Integration with existing system and High expense), opportunities (Surging incidences of neurovascular diseases, Increasing technological advancement, High demand for minimally invasive procedures, and Rising awareness), and challenges (Stringent regulations, Restricted access to advanced healthcare, and High risk of complications) influencing the growth of neurovascular devices market

Market Penetration: Comprehensive information on the product offered by the top players in the neurovascular devices market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the neurovascular devices market

Market Development: Comprehensive information on emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[futuristicpaintercat]

Neuro-interventional Devices Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Neurovascular and Neurological Disorders

The neuro-interventional devices market comprises devices that include embolic coils, flow diverters, distal access catheters, liquid embolics, coil assist stents, micro-catheters, balloon guiding catheters, neurovascular stents, and stent retrievers. These devices are used for the diagnosis and treatment of neurovascular and neurological disorders including cerebral aneurysm, carotid artery stenosis, arteriovenous malformation, and ischemic stroke. The increasing number of patients suffering from these disorders has boosted the demand for advanced neuro-interventional devices.

The Global neuro-interventional devices market is estimated to be valued at US$ 2.7 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the neuro-interventional devices are Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson and Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., NeuroVasc Technologies and Perflow Medical Ltd. These players are focusing on new product launches and geographic expansions to strengthen their market position. Some of the key opportunities in the market include growing preference for minimally invasive surgeries and the untapped potential in emerging economies. The increasing healthcare expenditure and growing demand for advanced medical technologies in countries such as China, India, Brazil, and Mexico will support the market growth. The rising medical tourism in Asian and Latin American countries also offers opportunities for manufacturers. These regions offer neuro-interventional surgeries at affordable costs as compared to developed nations in North America and Western Europe. Market Drivers The increasing prevalence of neurovascular and neurological disorders is one of the key drivers of the Neuro-Interventional Devices Market Share. According to estimates, nearly one-fourth of the population is likely to suffer a stroke during their lifetime. The growing number of ischemic strokes owing to changing lifestyle habits will eventually increase the demand for neurological devices. Advanced neuro-interventional devices are more effective and safer as compared to traditional open surgery which involves risks of infection, blood loss, and long recovery time. The advantages offered by minimally invasive endovascular procedures in reducing complications are expected to contribute to the high growth of the neuro-interventional devices market during the forecast period.

PEST Analysis Political: Government policies and regulations play a major role in determining the growth of the neuro-interventional devices market. Regulations on approval, adoption and reimbursement of new devices shape industry developments. Economic: Economic growth, rise in healthcare spending and increasing disposable income have positively impacted market growth over the last few years. However, the current economic slowdown caused by COVID-19 pandemic poses short term challenges. Social: Rising geriatric population and incidence of neurological disorders like stroke, aneurysm, arteriovenous malformation drives demand for neuro-interventional devices. Higher awareness and access to sophisticated treatment methods fuels adoption. Technological: Advancements in design, material and manufacturing improve effectiveness and reduce risks of procedures. Developments in 3D printing, navigation systems and bioabsorbable materials support new product innovations. Continued R&D lead to improved patient care. The North American region currently holds the largest share of the neuro-interventional devices market in terms of value. High healthcare spending, availability of advanced healthcare facilities, and favorable reimbursement policies are key factors supporting market growth in this region. The Asia Pacific region is anticipated to grow at the fastest rate over the forecast period. Rapidly developing healthcare infrastructure, increasing healthcare expenditure, rising incidence of brain disorders and growing demand for minimally invasive surgical techniques are driving the neuro-interventional devices market in Asia Pacific region. Countries like India, China and Japan are expected to provide lucrative opportunities.

Get more insights on Neuro-interventional Devices Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[themarketupdate]

Intracranial Aneurysm Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2024

Latest added Intracranial Aneurysm Market research study by Archive Market Research offers detailed outlook and elaborates market review till 2030. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are {Medtronic,Stryker,MicroPort Scientific Corporation.,Johnson & Johnson Services, Inc.,MicroVention Inc.,B. Braun Melsungen AG,Integra LifeSciences,RAUMEDIC AG,Terumo Corporation,Delta Surgical etc.  Click for Free Sample Report + All Related Graphs & Charts https://archivemarketresearch.com/report/intracranial-aneurysm-market-2484/sample-report The Intracranial Aneurysm Market size was valued at USD 1,380.58 billion in 2023 and is projected to reach USD XXX billion by 2032, exhibiting a CAGR of 9.12 % during the forecasts period. The latest edition of this report you will be entitled to receive additional chapter / commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation. Each of the segment analysis table for forecast period also high % impact on growth. The Global Intracranial Aneurysm segments and Market Data Break Down are illuminated below: {"Type: Surgical Clipping, Endovascular Coiling, Flow Diverters"}

Have Any Questions Regarding Global Intracranial Aneurysm Market Report, Ask Our Experts@ https://archivemarketresearch.com/report/intracranial-aneurysm-market-2484/enquiry-before-buy This report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article, we can also provide customized report as per company’s specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.

More Reports:

 https://archivemarketresearch.com/reports/intracranial-aneurysm-market-2484  https://archivemarketresearch.com/reports/clinical-trial-equipment-ancillary-solutions-market-2474   Contact US : Craig Francis (PR & Marketing Manager) Archive Market Research Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[market-insider]

Intracranial Aneurysm Treatment: Technological Advancements, Opportunities and Market Implications

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Intracranial Aneurysm Market Report Highlights

In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas

The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals

North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships

For More Details or Sample Copy please visit link @: Intracranial Aneurysm Market Report

Thus, the presence of key players in North America is expected to boost the regional market growth

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

[cmr-insights]

Transcatheter Embolization And Occlusion Devices Market Statistics and Global Analysis Report 2030

The Global Transcatheter Embolization and Occlusion Devices Market was valued at US$ 3,198.3 Million in 2022 and is anticipated to reach US$ 6,306.2 Million by the end of 2030 with a CAGR of 8.9% from 2023 to 2030.

Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/transcatheter-embolization-and-occlusion-devices-market/

These procedures also aid in removing improper connections between the arterial and venous systems and preventing or controlling abnormal bleeding. Moreover, they aid in the management of aneurysms. Unlike open and invasive surgical techniques, transcatheter embolization is particularly effective at controlling bleeding without being invasive. The use of TEO devices is another area where this technology is becoming more widely adopted. Non-coil products like embolization particles and liquid embolic aid minimally invasive surgery. Therefore, using these devices helps prevent issues like catheter entrapment, inaccurate installation, and balloon deflation brought on by coiling. Surgeons are increasingly moving towards non-coil devices to take advantage of these benefits, which is expected to increase revenue for TEO devices.

Transcatheter embolization is a useful therapeutic option for several gynecological and obstetric problems. It is feasible to skip surgery with minimally invasive transcatheter embolization procedures, which minimize mortality and morbidity while preserving a patient’s possibility for future conception. Under the direction of knowledgeable interventional radiologists and with the help of essential technological support, transcatheter embolization is utilized to cure an array of ulcerations in the female pelvis, like ectopic pregnancy, arteriovenous malformation, and advanced-stage cancer. It is also used to treat pelvic congestion syndrome and uterine fibroids symptoms after women have undergone the requisite examination. Embolization to treat uterine polyps has recorded 85% and higher global success rates for women.

Transcatheter Embolization and Occlusion Devices Market Amid COVID-19 Pandemic

Due to the COVID-19 outbreak, Transcatheter Embolization and Occlusion Devices have become increasingly important. In an effort to contain the spread of the disease, government-imposed lockdowns restricted movement and limited regular check-ups. Elective procedures were postponed, but patients infected with the virus were given priority. This has resulted in reduced demand for Transcatheter Embolization and Occlusion Devices. However, as the number of COVID-19 cases decreases and vaccination rates increase, there will likely be a surge in demand for these devices.

The healthcare sector is slowly returning to normal as patient visits resume, production facilities reactivate, and lockdown restrictions are lifted. The market for transcatheter embolization and occlusion devices was significantly affected by COVID-19, but there has been a sharp rise in sales of medical products in response to the pandemic. The medical industry continues to require more medical supplies due to the increase in COVID-19 cases worldwide, which has had an impact on every market. Despite stricter regulations, the medical supply and catheter sectors were able to meet demands for medical procedures. The pandemic resulted in a greater need for respiratory support equipment and life-supporting machines, but producers of this safety gear were able to keep up with demand.

It is projected that the demand for Transcatheter Embolization and Occlusion Devices will increase during the projection period. Despite the impact of the pandemic, the industry’s overall growth remains strong.

Increasing Prevalence of cardiovascular disorders respiratory disorders, and Cancer, the growing geriatric population, the surge in the need for treatment, patient awareness, technological advancements & increased healthcare expenditure to Boost the Transcatheter Embolization and Occlusion Devices Market

The demand for transcatheter embolization and occlusion devices is projected to rise due to several key factors in the healthcare landscape. These factors include an increasing incidence of cancer, respiratory illnesses, and cardiovascular diseases, a growing aging population, a higher demand for medical treatments, greater patient awareness, advancements in technology, and increased healthcare spending over the forecast period.

Transcatheter embolization and occlusion (TEO) is a minimally invasive treatment method. It involves the insertion of a synthetic embolus into a blood vessel via a catheter to reduce blood flow to a tumor or other targeted areas of the body. The market for these devices is expanding due to the rising demand for minimally invasive surgeries (MISs), a higher prevalence of specific diseases, technological innovations in more efficient systems, a shift from traditional clipping methods to coiling, and increased adoption of Transcatheter Embolization and Occlusion devices.

The use of transcatheter has seen significant growth in recent years, particularly with the transition from clipping to coiling and increased acceptance of transcatheter embolization and occlusion techniques. This growth is further boosted using minimally invasive procedures and the introduction of non-coil products like liquid embolic and embolization particles. The global increase in the prevalence of chronic diseases is another significant factor contributing to the expansion of the transcatheter embolization and occlusion market.

One of the primary drivers for the market is the aging global population. With improvements in healthcare infrastructure and available resources, people are living longer, and the average lifespan has increased. According to UN projections, by 2022, there will be over 727 million people aged 65 and older worldwide, with this elderly population expected to double in the next three decades to over 1.5 billion individuals. As the senior population grows, so will the demand for Transcatheter Embolization and Occlusion Devices.

Additionally, the market is expected to experience growth due to the increased introduction of new products and commercialization partnerships between major manufacturers and other businesses. For instance, Abbott’s Amplatzer steerable delivery sheath received CE mark and Health Canada certification. This innovative sheath is designed specifically for noninvasive left atrial appendage (LAA) occlusion procedures. Such developments are anticipated to drive the market for Transcatheter Embolization and Occlusion Devices further.

North America to spearhead the Transcatheter Embolization and Occlusion Devices Market.

The market in North America is propelled by the region’s highly developed healthcare system, rising provider awareness about transcatheter embolization and occlusion devices, and ongoing advancements in these technologies. In 2022, North America and Europe collectively represented the majority of revenue. Some of the factors driving the need for TEO devices in these areas include the presence of a modern well-defined regulatory framework, healthcare infrastructure, and skilled healthcare personnel to perform the operations. Throughout the predicted period, it is expected that both regions will continue to dominate.

North America is leading the transcatheter embolization and occlusion devices market due to the increasing prevalence of various chronic diseases. Due to this industry in North America is investing more and more in this sector. Moreover, the regulatory climate in North America is improving. Pharmaceutical businesses are finding it simpler to launch new drugs and products since regulatory agencies are creating clearer policies and procedures for the clearance of these therapies. The increasing elderly population in the country is one of the causes that is boosting the market. Increasing investments in R&D by the leading companies to develop new and advanced technologies are driving the market in the North America region. The markets in North America are being supported by rising patient awareness of the therapies, goods, and services available in the market for the treatment of different ailments including liver cancer, kidney cancer, venous blood clots, etc. Well-established infrastructure and medical services support the expansion of the local Transcatheter Embolization and Occlusion Devices market.

Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/transcatheter-embolization-and-occlusion-devices-market/

Companies operating in the Transcatheter Embolization and Occlusion Devices market include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories. These companies play a significant role in the development and distribution of devices used in minimally invasive procedures to treat vascular conditions.

[efrost]

Neurovascular Devices Market is set for a Potential Growth Worldwide: Excellent Technology Trends with Business Analysis

A Latest intelligence report published by AMA Research with title "Global Neurovascular Devices Market Outlook to 2027. This detailed report on Neurovascular Devices Market provides a detailed overview of key factors in the Global Neurovascular Devices Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development.

Vascular structure of the nervous tissues and blood vessels are majorly affected in the patient who is suffering from a neurovascular disorder. This leads to moderate to severe damage to the brain resulting in a condition such as cerebral haemorrhage and strokes. According to the report, stroke is the third leading cause of disability and death worldwide. The neurovascular device is used to treat several neurovascular diseases that affect the central nervous system as well as the blood vascular system. Increase in geriatric population across the country and upsurge in the number of patient suffering from the neurovascular disorder is expected to increase the demand for neurovascular devices. As per WHO, the global geriatric population (aged 65 years and above) is expected to rise from 7% in 2000 to 16% in 2050.

Major Players in this Report Include are

Johnson & Johnson (United States)

Terumo Corporation (Japan)

Medtronic, Plc (United States)

Abbott Laboratories (United States)

Stryker Corporation (United States)

Penumbra, Inc. (United States)

W. L. Gore & Associates, Inc. (United States)

Merit Medical Systems, Inc. (United States)

Microport Scientific Corporation (China) Market Drivers: Large Obese And Ageing Population

Constant Development In Ongoing Product

Favourable Medical Reimbursement

Market Trend: Advancement In The Manufacturing Process Of Neurovascular Devices

Opportunities: Research And Development In Field  Of Neurovascular Devices

Growing Concern Among Neurosurgeons About Procedures And Devices

Growing Number Of Researches In The Field Of Neurovascular Therapies

The Global Neurovascular Devices Market segments and Market Data Break Down by Type (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices), Application (Hospitals, Clinics, Ambulatory Surgical Units), Technology (Carotid Artery Angioplasty, Embolization and Coiling, Neurothrombectomy, Supporting Technologies), Disease Pathology (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Disease pathology) Geographically World Neurovascular Devices markets can be classified as North America, Europe, Asia Pacific (APAC), Middle East and Africa and Latin America. North America has gained a leading position in the global market and is expected to remain in place for years to come. The growing demand for Global Neurovascular Devices markets will drive growth in the North American market over the next few years.

Presented By

AMA Research & Media LLP

[industryforecastnews]

Intracranial Aneurysm Market Size To Reach $2,331.09 Million By 2030

Intracranial Aneurysm Market Growth & Trends

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

A recent Global Burden of Disease study predicts a doubling of individuals affected by brain diseases by 2050, with about 40% of the current global population already impacted. Technological advancements and increasing preference for targeted therapy approach are factors expected to drive the market growth in the forecast period.

The prevalence of a variety of health disorders, including brain aneurysms, increases as the world's population ages. Elderly individuals are more likely to develop aneurysms, especially in the brain. For instance, as per the reports published by University Of Minnesota in March 2023, the Brain Aneurysm Foundation states that 1 in 50 Americans or approximately 6.7 million people-have an unruptured brain aneurysm. Annually, about 30,000 individuals in the nation experience the rupture of a brain aneurysm, translating to roughly one rupture occurring every 18 minutes.

Request a free sample copy or view report summary: Intracranial Aneurysm Market Report

Intracranial Aneurysm Market Report Highlights

In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas

The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals

North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships

Thus, the presence of key players in North America is expected to boost the regional market growth

Regional Insights

North America dominated the market with the revenue share of 26.65% in 2023 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke. In addition, the increasing occurrence of intracranial aneurysms and the escalating demand for minimally invasive surgeries are driving the market growth in this region. Moreover, numerous initiatives being taken by different organizations are expected to boost market growth. For example, The Bee Foundation (TBF), a non-profit entity, is dedicated to raising awareness and decreasing the mortality rates associated with cerebral aneurysms via pioneering research.

Intracranial Aneurysm Market Segmentation

Grand View Research has segmented the global intracranial aneurysm market based on type, end-use, and region:

Intracranial Aneurysm Type Outlook (Revenue, USD Million, 2018 - 2030)

Surgical Clipping

Endovascular Coiling

Flow Diverters

Others

Intracranial Aneurysm End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Clinics

Others

Intracranial Aneurysm Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East & Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players of Intracranial Aneurysm Market

Medtronic plc

Stryker Corporation

MicroPort Scientific Corporation.

Johnson & Johnson Services, Inc.

MicroVention Inc.

B. Braun Melsungen AG

Integra LifeSciences

RAUMEDIC AG

Terumo Corporation

Delta Surgical

Browse Full Report: Intracranial Aneurysm Market Report

[factmrblog]

The global cerebral aneurysm market is valued at $1.3 billion in 2022  , and demand for cerebral aneurysm treatment and solutions is expected to  grow at a CAGR of  10%,  reaching a market size of $3.4 billion  in 2032 .

Intracranial aneurysm solutions are further classified as intravascular coiling, flow diverter, and surgical clipping. According to this analysis, endovascular coiling procedures currently   have a market share of over 80% .

Download a sample copy of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7817?VM

The readability score of the Intracranial Aneurysm Market Demand report is good as it provides a chapter-by-chapter layout with each section broken into smaller sections.

Reports include graphs and tables showing the entire assembly. The graphical presentation of confirmed and estimated values ​​of key segments is visually appealing to the reader. 

This Intracranial Aneurysm Market Perspective report discusses important dynamics such as drivers, restraints, and opportunities for key players in the Intracranial Aneurysm Market and competitive analysis along with key stakeholders and emerging players involved in manufacturing the product.

The extended oral antibiotics market key trends analysis also provides the dynamics affecting future sales and demand during the forecast period.

market player

B.Braun Melsungen AG

Integra Life Science Corporation

johnson and johnson

Medtronic

Microport Scientific Corporation

Laumedic AG

striker

Terumo Corporation

How can the Intracranial Aneurysm Market report make a difference to the revenue impact and strategies of businesses?

Fact.MR is committed to providing a comprehensive assessment of opportunities in different geographies and technology sectors. The study also provides neat data-driven insights into the intracranial aneurysm market and how all segments are growing. Some of the ways research can have a measurable impact is by providing an evidence-based perspective on:

An index of the attractiveness of emerging product/technology types across different products in the intracranial aneurysm market.

Microeconomic factors that may hinder the outlook for some key sectors

Recent surge in research and development (R&D) funding for key intracranial aneurysm markets

New business models disrupting demand dynamics in key sectors

Regional markets to be future growth engines and industry trends to support them

Challenges to overcome that can give industry players a competitive edge

Segmentation of Intracranial Aneurysm Industry Research

·         By type:

Intravascular coiling

flow diverter

surgical clipping

etc

·         End users:

hospital

clinic

etc

·         By region:

North America

Latin America

europe

East Asia

South Asia and Oceania

thing

Get full access to all reports:

https://www.factmr.com/checkout/7817

The questionnaires answered in the Market Outlook for Detergent Polymers report are as follows:

What are the key strategies deployed by the large players to maximize Intracranial Aneurysm market growth?

What are the major challenges faced by players in the demand for intracranial aneurysm market?

With the advent of technological advancements, how will the Intracranial Aneurysms market environment change during the forecast period?

What does the player bring to the table that is unique as a strategy and easy-to-imitate for new investors in Intracranial Aneurysm market size?

What difference does the insights and market forecasts provided in the Fact.MR report on detergent polymer demand make?

This study takes a closer look at major economic disruptions, with a focus on the recent COVID-19 pandemic disruption.

An assessment of key growth drivers highlights the attractiveness of new automation technologies and provides readers with insight into the prospects of these technologies over the forecast period.

This study attempts to provide a balanced view of opportunities in mature and most underperforming markets.

It scrutinizes industry trends that have shaped recent government policy.

We provide descriptions of major breakthroughs in every sector that could significantly change the course of the market.

It provides an incisive analysis of the socio-political environment in which key markets operate and how they will affect the profitability of the overall cerebral aneurysm market.

We analyze how collaborations and partnerships between players from different industries will shape key growth dynamics in the near future.

Evaluate the role of different funding tiers for new growth vehicles in key regional markets. 

Contact: USA Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Phone: +1 (628) 251-1583 Email: sales@factmr.com

[impossibledeanmakerwombat]

Intracranial Aneurysm Market Growth, Trends Analysis Report 2032

The global market for intracranial aneurysms is anticipated to grow at a promising CAGR of 8.8% between 2022 and 2032. The market is expected to reach USD 2.56 billion by 2032, up from its USD 1.2 billion market value in 2022.

The intracranial aneurysm market is growing as a result of recent technical advancements, an increase in brain aneurysm cases and their complications, and the introduction of less invasive therapies.

A growing number of intracranial aneurysms in the brain are caused by a bulge in the wall of a brain artery, according to a global study on the intracranial aneurysm market. Swelling, ballooning, and broadening are the results. Aneurysms weaken the walls and make it hard for the nerves to function properly.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15291

The expanding intracranial aneurysm market size is attributed to the new advanced t echnology integrating with intracranial aneurysm treatment and solutions. As the risk of walls bursting increases, end user patients and treatment centers adopt the intracranial aneurysm treatment and solution methods.

Latest technological developments, increasing cases of brain aneurysm & its complications along with the introduction of minimally invasive procedures are gaining traction for the intracranial aneurysm market.

Key Takeaways:

The type category has three major segments, Surgical Clipping, Endovascular Coiling, and Flow Diverters. The endovascular coiling segment dominates the market while holding a market share of 85.3% of the global share.

The minimally invasive techniques go through the catheter to locate the aneurysm in the brain. Growing hypertension among the geriatric population leads people to a higher chance of brain aneurysms and other diseases.

The end user category is dominated by the hospital segment, holding 89.5% of the global market. The segment grows at a promising CAGR of 8.9% through the forecast period, attributed to application of technologically advanced tools in operation theaters and intensive care units along with increased number of healthcare units.

North America holds 27% of the global share in the global intracranial aneurysm market in 2022. The growing intracranial aneurysm market in the North American region is attributed to the growing healthcare facilities, government investments, and the rising cases of brain aneurysms.

Asia Pacific region is anticipated to thrive at the highest CAGR of 12.7% through 2032. Presence of emerging economies like India and China that are investing huge capital in building their healthcare infrastructure, advancing and making it tech-enabled.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15291

“The Intracranial aneurysm market analysis states that the use of new platforms like Artificial intelligence, big data, and the internet of things (IOT) are integrating with the treatment solutions. Countries such as the U.S., the U.K., and Germany have witnessed a high prevalence of intracranial aneurysms in recent years. Neuro Intervention India states that approximately 6.0 million people in the U.S. develop an unruptured intracranial aneurysm. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices, fueling the demand for intracranial aneurysm treatment solutions”  says a Future Market Insights analyst.

Competitive Landscape

The Intracranial aneurysm market has various key competitors that focus on expanding healthcare centers with advanced technology. The key competitors understand and focus on new techniques that are aneurysm-specific and target wall healing and blood prevention. This makes the competitive landscape more dynamic and versatile, owing to the expansion of the intracranial aneurysm market.

The key competitors flourishing in the growth of intracranial aneurysm treatment solutions are Medtronic, Microport Scientific Corporation, B. Braun, Stryker, Johnson and Johnson Services Inc., Microvention Inc., and Codman Neuro (Integra Lifesciences).

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15291

Recent Developments

MicroPort Scientific Corporation has introduced new therapies for neurovascular intervention that resolve potential issues related to brain aneurysms, offering specific tools to surgeons. This fuels the sales of intracranial aneurysm treatment solutions.

Stryker has added the neuroform atlas stent system that is further used in conjunction with metal coils that help in packing Aneurysms (week walls and blood vessel scar) in the brain. This is anticipated to help multiple surgeons across the globe.

The Brain Aneurysm Treatment market is a rapidly growing industry focused on the development and commercialization of therapeutic options for the treatment of intracranial aneurysms. Intracranial aneurysms are a type of cerebrovascular disorder that can result in serious complications such as brain damage, stroke, and even death.

Intracranial aneurysm Market by Segmentation

By Type Outlook:

Surgical Clipping

Endovascular Coiling

Flow Diverters

By Application Outlook:

Hospitals

Clinics

Others